. A greater proportion of the nuclear YAP in BPs is dephosphorylated at serine127/112 in embryonic ferret and fetal human than embryonic mouse neocortex.
Related to Figure 1.
(A) Triple immunofluorescence for Sox2 (white), total YAP (i.e., YAP irrespective of phosphorylation; green) and phospho-YAP (P-serine 127; red), combined with DAPI staining (blue), on a cryosection of human 11 wpc neocortex; the SVZ is shown. Selected Sox2 and YAP (green) double-positive BP nuclei are outlined by white lines, as determined from DAPI-staining and/or Sox2 immunofluorescence. Yellow arrowheads indicate representative areas of cytoplasm used to standardize the immunofluorescence intensity for total YAP and phospho-YAP to each other. Note the barely detectable levels of phospho-YAP compared to total YAP immunoreactivity in the indicated Sox2-positive nuclei. Scale bar, 10 µm.
(B) Quantitation of dephospho-YAP in Sox2-positive BP nuclei in the SVZ of mouse E13.5, ferret E36 and human 11 wpc neocortex, by comparison of total YAP and phospho-YAP immunofluorescence. Cryosections were subjected to triple immunofluorescence for Sox2, total YAP and phospho-YAP as described in panel A for human neocortex. One to two images per embryo/fetus (1 image per cryosection) were taken, and 30 randomly picked Sox2-positive nuclei in the SVZ were scored per image, as follows. First, for each image, the mean immunofluorescence intensity values for total YAP and for phospho-YAP from three representative areas of cytoplasm (see arrowheads in A) were determined, to serve as internal standards for the comparison of nuclear total YAP and nuclear phospho-YAP. The ratio of these two values was used to adjust the immunofluorescence intensity values for nuclear phospho-YAP relative to the immunofluorescence intensity values for nuclear total YAP. Then, for each nucleus, the adjusted immunofluorescence intensity value for phospho-YAP was subtracted from the immunofluorescence intensity value for total YAP, to yield the value for dephospho-YAP. The values obtained for nuclear dephospho-YAP were averaged for each embryo/fetus. Data are the mean of 7 mouse, 4 ferret and 4 human embryos/fetuses. Error bars indicate SD; *** P <0.001 (one-way ANOVA test, post-hoc Tukey HSD). 
Methods S1 Original and English-translated informed consent form
During the development of the brain, neurons are being generated. This occurs in humans in a different manner than in laboratory animals such as the mouse. Therefore, the current knowledge about how neurons are being generated in the mouse brain has only limited relevance for humans. However, understanding how neurons are generated during the development of the human brain is a prerequisite for regenerating, in the future, neurons which have been destroyed by diseases such as Alzheimer, Parkinson or stroke. The aim of the project therefore is to obtain information on the generation of neurons from the progenitor cells present in the early embryo.
Description of the research project
The tissue will be fixed and examined histologically to determine which marker molecules for the generation of neurons are expressed in which progenitor cells. In individual cases, the tissue will also be examined unfixed to investigate cell division and cell migration processes, using suitable dyes and substances which may influence the generation of neurons. Subsequently, the nervous tissue will be fixed and examined as above. The tissue will be used exclusively for these in vitro laboratory tests. The investigations thus described will be carried out in compliance with all legal rules and laws.
Foreseeable risks and discomfort
Due to your agreement that the tissue can be used for the described scientific investigations, no additional health risks or discomfort will arise.
Aims of the research project
The aim of the project is to gain a better understanding about the generation of neurons in the human brain. This is also a basic prerequisite for regenerating, in the future, neurons that have been destroyed, for example, by neurodegenerative diseases.
General aspects of the research project
The tissue samples will be examined at the Max Planck Institute of Molecular Cell Biology and Genetics, a partner institution of the University Hospital and the Faculty of Medicine Carl Gustav Carus of TU Dresden. All applicable laws will be observed, and full data protection is assured. The planned scientific investigations and their results will not allow any inference as to your identity. It is possible that the results of the planned scientific research could lead to the acquisition of intellectual property rights (patents) and the commercial exploitation of results. In this case, you would not receive any financial bonus.
Expected benefits
For you as a patient, there will be no benefits or income. By agreeing to the research described above, you can contribute to making a better diagnosis and treatment of certain neurological disorders possible in the future.
Voluntary participation
Participation in the described research project is completely voluntary. A refusal will not adversely affect your relationship with the physician or hospital team, or your treatment.
Resignation from participating in the described research project is possible at any time without giving reasons, without any disadvantage for you.
Data protection
All data concerning the tissue samples (for example, the pregnancy week) will be completely anonymized. The scientists doing the described research will be completely unaware of your identity. A communication about possible research results to you personally or to your relatives is not planned. A publication of possible research results would take place without personal reference or other indications as to your identity. All applicable laws and regulations of data protection will be observed.
Insurance
No additional insurance is foreseen in connection with the research project, as there will be no additional risks, that is to say, beyond the already planned medical measures.
Contact person
Of course, for any question or problem, your physician will be available for you. Please contact the following physician: Name of physician:___________________ Department of Obstetrics and Gynecology Phone: ___________________ Please take your time to read this information, and do not hesitate to ask your physician if anything should be unclear. You should keep a copy of this document after you and your physician have signed it.
